Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Open-market buy 10% owner bought 81,400 shares at $7.79 ($634,106)
  2. 4 Open-market buy 10% owner bought 114,300 shares at $7.86 ($898,398)
  3. 4 Open-market buy 10% owner bought 26,300 shares at $7.93 ($208,559)
  4. 4 Open-market buy 10% owner bought 72,517 shares at $8.01 ($580,861)
  5. 4 Open-market buy 10% owner bought 2,000 shares at $8.04 ($16,080)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.13 ($81,300)
  10. 4 Open-market buy 10% owner bought 42,600 shares at $8.15 ($347,190)
  11. 4 Open-market buy 10% owner bought 3,800 shares at $8.19 ($31,122)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale President and CEO sold 35,000 shares at $8.68 ($303,681)
  17. 4 Open-market buy 10% owner bought 3,065 shares at $8.19 ($25,102)
  18. 4 Open-market buy 10% owner bought 37,400 shares at $8.19 ($306,306)
  19. 4/A Other acquisition Director acquired 0 shares (other)
  20. 4 Open-market buy 10% owner bought 21,700 shares at $8.19 ($177,723)

Page 26 of 30 · 591 filings